Abstract

Organ damage in patients with systemic lupus erythematosus (SLE) occurs as a consequence of the disease itself, the therapy applied and the accompanying conditions and complications. Organ damage predicts further organ damage and is associated with an increased risk of death. This study aimed to assess the degree of irreversible organ changes in SLE patients, using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index (SDI); to establish correlations between organ damage and disease activity, quality of life, intensity of fatigue and serological factors; and to ascertain the risk factors for organ damage. Cross-sectional single-center study conducted at the Institute for Treatment and Rehabilitation "Niška Banja", Niš, Serbia. 83 patients with SLE were enrolled: 58 patients formed the group with organ damage (SDI ≥ 1), and 25 patients without organ damage served as controls (SDI = 0). Organ damage correlated with age (P = 0.002), disease duration (P = 0.015), disease activity (grade 1, P = 0.014; and grade 2, P = 0.007), poor quality of life, severe fatigue (P = 0.047) and treatment with azathioprine (P = 0.037). The following factors were protective: use of hydroxychloroquine (P = 0.048) and higher scores obtained for the physical (P = 0.011), mental (P = 0.022) and general health (P = 0.008) domains. It is very important to evaluate risk factors for organ damage in the body, including physicians' overall assessment, to try to positively influence better treatment outcomes.

Highlights

  • The multisystemic nature of systemic lupus erythematosus (SLE), its involvement of vital organs and its unpredictable disease course with exacerbations and remissions give rise to the possibility of development of irreversible changes in individual organs even at early phases of the disease, and after several years.[1]

  • Adequate evaluation of disease activity, assessment of organ damage using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for SLE (SDI)[4] and quality of life assessment among SLE patients contribute towards better surveillance and treatment, and improved prognosis for the disease.[5,6]

  • Any significant difference in time elapsed from the onset of symptoms to diagnosis (t = 0.725; P = 0.471)

Read more

Summary

Introduction

The multisystemic nature of systemic lupus erythematosus (SLE), its involvement of vital organs and its unpredictable disease course with exacerbations and remissions give rise to the possibility of development of irreversible changes in individual organs even at early phases of the disease, and after several years.[1]. Adequate evaluation of disease activity, assessment of organ damage using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index for SLE (SDI)[4] and quality of life assessment among SLE patients contribute towards better surveillance and treatment, and improved prognosis for the disease.[5,6]. Organ damage in patients with systemic lupus erythematosus (SLE) occurs as a consequence of the disease itself, the therapy applied and the accompanying conditions and complications. OBJECTIVE: This study aimed to assess the degree of irreversible organ changes in SLE patients, using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) damage index (SDI); to establish correlations between organ damage and disease activity, quality of life, intensity of fatigue and serological factors; and to ascertain the risk factors for organ damage. CONCLUSION: It is very important to evaluate risk factors for organ damage in the body, including physicians’ overall assessment, to try to positively influence better treatment outcomes

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call